A Randomized, Double-Blind, Placebo-Controlled Trial of Omalizumab Combined with Oral Immunotherapy (OIT) in the Treatment of Cow's Milk Allergy (CMA): Safety of Dosing von Kim, Jennifer S., Dr, Wood, Robert A., MD, FAAAAI, Lindblad, Robert, MD, Noone, Sally A., Ms, Paterakis, Melissa N., Ms, Henning, Alice, MS, Nadeau, Kari C., Dr, Spann, Kyrsten, Sampson, Hugh A., MD, FAAAAI

Volltext